Equity
Non-Controlling Interests
Bristol-Myers Squibb Non-Controlling Interests decreased by 11.1% to $48.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 17.2%, from $58.00M to $48.00M. Over 4 years (FY 2020 to FY 2024), Non-Controlling Interests shows a downward trend with a -3.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ4 2025
How to read this metric
Changes reflect the ownership structure of consolidated entities and the performance of those specific subsidiaries.
Detailed definition
Noncontrolling interests represent the portion of equity in a subsidiary that is not attributable, directly or indirectl...
Peer comparison
Common in companies with complex organizational structures or joint ventures.
Metric ID:
noncontrolling_interestsHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $66.00M | $71.00M | $60.00M | $65.00M | $61.00M | $63.00M | $57.00M | $62.00M | $57.00M | $64.00M | $55.00M | $58.00M | $54.00M | $58.00M | $53.00M | $59.00M | $54.00M | $48.00M |
| QoQ Change | — | +7.6% | -15.5% | +8.3% | -6.2% | +3.3% | -9.5% | +8.8% | -8.1% | +12.3% | -14.1% | +5.5% | -6.9% | +7.4% | -8.6% | +11.3% | -8.5% | -11.1% |
| YoY Change | — | — | — | — | -7.6% | -11.3% | -5.0% | -4.6% | -6.6% | +1.6% | -3.5% | -6.5% | -5.3% | -9.4% | -3.6% | +1.7% | +0.0% | -17.2% |
Range$48.00M – $71.00M
CAGR-7.2%
Avg YoY Growth-5.5%
Median YoY Growth-5.1%
Current Streak2 quarters decline
Non-Controlling Interests at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's non-controlling interests?
- Bristol-Myers Squibb (BMY) reported non-controlling interests of $48.00M in Q3 2025.
- How has Bristol-Myers Squibb's non-controlling interests changed year-over-year?
- Bristol-Myers Squibb's non-controlling interests decreased by 17.2% year-over-year, from $58.00M to $48.00M.
- What is the long-term trend for Bristol-Myers Squibb's non-controlling interests?
- Over 4 years (2020 to 2024), Bristol-Myers Squibb's non-controlling interests has grown at a -3.1% compound annual growth rate (CAGR), from $60.00M to $53.00M.
- What does non-controlling interests mean?
- The portion of a subsidiary's equity owned by outside parties.